Q. What background work is being done to ensure, RACE can recruit patients for the upcoming trial?
A- Lots of talking to KOLs and doctors and verifying with them, before releasing the strategy. And is one of the main priorities of the clinical/preclinical team.
My opinion-Solid results in Sheba2 results has already landed an investigator trial in a short time. The results will also be extremely useful while recruting patients.
We also have a wider range of different cancers for Pa1/b. Also, a no brainer for anyone receiving Doxo, to add Bisantrene for heart protection.
- Forums
- ASX - By Stock
- Ann: Race Oncology 2023 Chair's Address & AGM Presentation
Q. What background work is being done to ensure, RACE can...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M |
Open | High | Low | Value | Volume |
$1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 649 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 649 | 1.575 |
1 | 325 | 1.540 |
1 | 1138 | 1.535 |
1 | 10000 | 1.525 |
1 | 2239 | 1.520 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 3000 | 1 |
1.620 | 2192 | 2 |
1.630 | 6183 | 1 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
SPONSORED BY The Market Online